Latest Period
Q1 2026
Security Snapshot
ImageneBio, Inc. - Common Stock, $0.001 par value (IMA) Institutional Ownership
CUSIP: 45175G207
13F Institutional Holders and Ownership History from Q3 2025 to Q1 2026
Institutions Reporting
39
Shares (Excl. Options)
5,355,955
Price
$5.00
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.001 par value
- Symbol
- IMA on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 5,355,955
- Total 13F value
- $26,770,536
- Portfolio coverage rank
- 0%
- Share change
- +469,907
- Value change
- +$1,947,403
- Number of holders
- 39
- Shares outstanding
- 11,212,141
- SEC-reported price per share
- $5.77
- Insider filing price
- $5.77
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- IMA - ImageneBio, Inc. - Common Stock, $0.001 par value is tracked under CUSIP 45175G207.
- 39 institutions reported positions in Q1 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 40 to 39 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $32,916,990 to $26,770,536.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 39 institutions filings for Q1 2026.
Security key
45175G207
Latest holder period
Q1 2026
13F holders
39
13D/G owners
8
CIK / CUSIP context first
Open Q1 2026 holders
IMA full holder history
ImageneBio, Inc. SEC filings
ImageneBio, Inc. company facts
ImageneBio, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45175G207:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
8
Security
IMA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 13% | $7,475,225 | 1,495,045 | ORBIMED ADVISORS LLC | 14 Apr 2026 | |||
| Trails Edge Capital Partners, LP | 9.9% | $5,882,360 | 1,176,472 | Trails Edge Capital Partners, LP | 14 Apr 2026 | |||
| BIOTECHNOLOGY VALUE FUND L P | 9.9% | +39% | $6,715,512 | +$1,862,795 | 1,110,002 | +38% | BVF PARTNERS L P/IL | 31 Mar 2026 |
| Blue Owl Capital Holdings LP | 8.5% | +16% | $5,803,989 | +$820,090 | 959,337 | +16% | Blue Owl Capital Holdings LP | 31 Mar 2026 |
| Omega Fund VI, L.P. | 8.4% | $4,681,110 | 936,222 | Otello Stampacchia | 14 Apr 2026 | |||
| Funicular Funds, LP | 5.8% | $4,211,322 | 643,933 | Funicular Funds, LP | 29 Dec 2025 | |||
| Atlas Venture Fund X, L.P. | 2.1% | 241,800 | Atlas Venture Fund X, L.P. | 25 Jul 2025 | ||||
| BML Investment Partners, L.P. | 1.9% | 220,832 | Leonard Braden Michael | 25 Jul 2025 |
As of 31 Mar 2026, 39 institutional investors reported holding 5,355,955 shares of ImageneBio, Inc. - Common Stock, $0.001 par value (IMA). This represents 48% of the company’s total 11,212,141 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
47%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BVF INC/IL | 9.9% | 1,110,002 | +38% | 0.18% | $5,550,010 |
| Blue Owl Capital Holdings LP | 8.6% | 959,337 | +16% | 1.3% | $4,796,685 |
| Cable Car Capital, LP | 6.7% | 754,749 | +17% | 1.3% | $3,773,745 |
| Omega Fund Management, LLC | 4.1% | 455,361 | 0% | 1.4% | $2,276,805 |
| ORBIMED ADVISORS LLC | 3.4% | 378,556 | 0% | 0.04% | $1,892,780 |
| RTW INVESTMENTS, LP | 3% | 334,445 | 0% | 0.02% | $1,672,225 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.9% | 325,155 | 0% | 0% | $1,625,775 |
| BML Capital Management, LLC | 1.8% | 200,730 | +13% | 0.65% | $1,003,650 |
| BlackRock, Inc. | 1.2% | 129,214 | -1.8% | 0% | $646,070 |
| CITADEL ADVISORS LLC | 1.1% | 124,345 | +44% | 0% | $621,725 |
| RENAISSANCE TECHNOLOGIES LLC | 0.73% | 81,696 | +24% | 0% | $408,480 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.59% | 66,666 | 0% | 0% | $333,330 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.53% | 59,929 | +11% | 0% | $299,672 |
| NEA Management Company, LLC | 0.45% | 50,005 | 0% | 0.01% | $250,025 |
| HSBC HOLDINGS PLC | 0.31% | 34,884 | +1.9% | 0% | $165,699 |
| Rangeley Capital, LLC | 0.29% | 32,590 | +79% | 0.18% | $162,950 |
| Sofinnova Investments, Inc. | 0.28% | 31,884 | 0% | 0.01% | $159,420 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 0.27% | 30,000 | +13% | 0.14% | $150,000 |
| VANGUARD FIDUCIARY TRUST CO | 0.24% | 27,286 | 0% | 0% | $136,430 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.24% | 26,663 | +42% | 0% | $133,315 |
| Shay Capital LLC | 0.17% | 19,130 | -18% | 0.01% | $95,650 |
| Aldebaran Capital, LLC | 0.17% | 18,566 | -2.6% | 0.07% | $92,830 |
| MORGAN STANLEY | 0.16% | 18,339 | +70% | 0% | $91,695 |
| XTX Topco Ltd | 0.13% | 15,112 | +24% | 0% | $75,560 |
| HRT FINANCIAL LP | 0.12% | 13,909 | 0% | $69,000 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
3
Latest
Q1 2026
Rows shown
1-3 of 3